VistaJet Presents Exceptional Travel Experiences for The Collection of Peggy and David Rockefeller
Three highly personalized programs for art lovers to enhance the most significant philanthropic auction ever presented
LONDON, Feb. 08, 2018 (GLOBE NEWSWIRE) -- VistaJet, the first and only global private aviation company, showcases today three exclusive experiences to enrich the exhibitions and global tour of The Collection of Peggy and David Rockefeller, the most valuable auction of a private collection entirely dedicated to raising funds for philanthropic causes.
Following the unveiling of early highlights in Hong Kong last November, the global public tour will move to London (February 21 - March 8), Paris (March 16 - 21), Beijing (April 6 - 7), Los Angeles (April 6 - 12) and Shanghai (April 10 - 11), ahead of the final exhibition in New York at Christie's Rockefeller Center from April 28 until the sale on May 7 - 11. With each stop on the pre-sale tour, additional works of art and objects will be revealed.
With 80% of customers regularly investing in art, VistaJet flies some of the world's most prominent collectors. Art has always integrated organically into the brand and as the company continuously strives to provide exceptional and curated experiences for members, anytime and anywhere, VistaJet's three fully customizable The Art of Flying Experiences* will offer exclusive previews, private dinners, lectures and talks, enriching their engagement with the Rockefeller pieces.
The World of Art Experience will offer customers the opportunity to travel to all of The Collection of Peggy and David Rockefeller exhibitions on-board VistaJet for a private tour of the emblematic collection at each location. By booking this multi-leg journey, VistaJet will transport clients and their art at no additional cost on flights anytime, anywhere** and the experience will also include a year-long membership*** to The Cultivist, the global arts club.
The Direct Experience will offer any guest flying with VistaJet to any of The Collection of Peggy and David Rockefeller exhibitions in London, Paris, Beijing, Shanghai, Los Angeles or New York, an invitation to receive a complimentary membership to VistaJet Direct worth $10,000. The Direct membership gives clients access to available VistaJet private flights at special rates from any mobile device, through the world's first end-to-end business jet app.
The third exclusive opportunity, The Rockefeller Experience , will allow up to 10 guests traveling with VistaJet on one of its iconic silver and red jets to New York, a rare opportunity for a behind the scenes private discovery tour of Kykuit, the historical National Trust landmark of the Rockefeller Estate in Pocantico Hills, before enjoying a Rockefeller-inspired multi-taste feast at an exclusive Upstate New York venue. Guests will then be invited for a personal tour of The Collection of Peggy and David Rockefeller exhibition in New York, and to view the live auction at Christie's New York with leading art experts.
"The Collection of Peggy and David Rockefeller is a unique collection of the finest works of art and objects," said Nina Flohr of VistaJet. "The fact that 100% of the proceeds from the auction of the collection will be donated to charities worldwide is a remarkable philanthropic effort. We fully support the Rockefellers' commitment to giving back, and our sponsorship is VistaJet's way to facilitate and contribute to the exhibitions, auctions, and ultimately, the Rockefeller family's charitable mission. We are very proud to support their initiative as the key global partner."
The global nature of the auction and exhibitions aligns seamlessly with the VistaJet brand and its global reach. With a fleet of over 70 super-mid and long range identically designed aircraft, VistaJet guarantees availability within 24 hours to its customers, no matter where in the world they are based. The sponsorship of such a landmark collection is a way for VistaJet to support not only the arts, but David and Peggy Rockefeller's philanthropic endeavours.
Sales of The Collection of Peggy and David Rockefeller will be conducted in keeping with David Rockefeller's pledge to direct the majority of his wealth to philanthropy. All the Estate proceeds will be donated to charities, directly benefiting the philanthropic missions that have been maintained by the family for decades.
Find more info on how to enjoy The Collection of Peggy and David Rockefeller with VistaJet at VistaJet.com/TheArtOfFlying
Price on request - dependent on origin location, availability, cabin size, airport and slot restrictions..
** Insurance and transportation terms and conditions apply.
*** Membership to The Cultivist upon application.
VistaJet Press Contacts:
Global and EMERI: Jennifer Farquhar | M: +44 7834 335505 | firstname.lastname@example.org
APAC: Amy Yang | M: +852 9080 3985 | email@example.com
USA: Michael Salamanca | M: +1 917 755 3734 | firstname.lastname@example.org
VistaJet is the first and only global aviation company. On its fleet of silver and red business jets, VistaJet has flown corporations, governments and private clients to 187 countries worldwide. Founded in 2004 by Thomas Flohr, the company pioneered an innovative business model where customers pay only for the hours they fly, free of the responsibilities and asset risks linked to aircraft ownership. VistaJet's signature Program service offers customers a bespoke subscription of flight hours on its fleet of mid and long-range jets, to fly them anywhere and at any time.
More VistaJet information and news at vistajet.com
Photos accompanying this announcement are available at
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: VistaJet Ltd via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
Luxembourg Announced as SNOMED International's Newest Member24.5.2018 15:16 | Pressmeddelande
London, United Kingdom, May 24, 2018 (GLOBE NEWSWIRE) -- SNOMED International and Agence eSanté Luxembourg are pleased to announce that Luxembourg has joined the organization as its thirty-second Member. Luxembourg, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority. Agence eSanté, Luxembourg's national agency for the exchange and sharing of medical data, has set an overall mission to facilitate clinical information exchange both within Luxembourg and across other international actors. To work towards this reality, the agency has taken part in discussions about standardization across Europe, a contributing building block achieved with its membership in SNOMED International. With their membership, Agence eSanté has committed their support for the use of structured clinical terminology. When applied to the health sector, interoperability ensures that information systems, and through them h
SEMAFO Signs Underground Mining Services Contract with AUMS24.5.2018 14:00 | Pressmeddelande
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- SEMAFO Inc. (TSX:SMF) (OMX:SMF) reports that it has signed a mining services contract with African Underground Mining Services ("AUMS") to provide turnkey mining services for Siou underground. AUMS is a well-known and reputable mining contractor with underground experience in Burkina Faso and across Africa. Under the mining services contract, AUMS will be responsible for supplying the mining fleet and a skilled labour force for Siou underground in addition to ensuring development, production and auxiliary services. SEMAFO will provide technical services including geology and engineering as well as leveraging the existing surface infrastructure at Mana. The mining services contract has a term of 70 months. The economic terms of the mining services contract are consistent with the economics presented in the Mana pre-feasibility study filed March 29, 2018 on SEDAR. Preparatory work has already commenced on Siou underground with full project deplo
Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors24.5.2018 13:00 | Pressmeddelande
- IND Accepted in April by the U.S. FDA for MCLA-158 - UTRECHT, The Netherlands, May 24, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the first patient has been dosed in a Phase 1, first-in human clinical trial of MCLA-158 in patients with solid tumors with an initial focus on metastatic colorectal cancer. The trial will be conducted in Europe, where several Clinical Trial Applications (CTAs) have been approved to date. The Company also announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for MCLA-158, which was accepted by the FDA in April 2018. With this acceptance, Merus plans to open additional sites for this trial in the United States. MCLA-158 is designed to bind to cancer stem cells expressing leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) and epidermal grow
PRA Named International Clinical Research Company of the Year24.5.2018 10:00 | Pressmeddelande
RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the fifth year in a row that PRA has received this award. "This award celebrates excellence in the clinical research industry and we are honored to once again be recognized by our peers," said Colin Shannon, President and Chief Executive Officer. "This award is possible thanks to the incredibly talented PRA team members we have working around the world who are deeply committed to their work in bringing new and life-saving therapies to the patients who need them." PRA also swept the Clinical Research Associate and Clinical Trial Administrator categories capturing a total of 11 awards. These awards follow PRA's recognition earlier this month in the PharmaTimes Americas competition where PRA also received 11 awards, including Company of the Year. The PharmaTimes, International Cli
Immunicum AB: Inbjudan till investerarträff24.5.2018 08:00 | Pressmeddelande
Pressmeddelande 24 maj 2018 Immunicum AB: Inbjudan till investerarträff Immunicum AB (publ; IMMU.ST) meddelade i dag att bolaget kommer att anordna en investerarträff i Kalmar den 13 juni kl. 18:00 CEST. Carlos de Sousa, Immunicums VD, kommer att hålla en presentation av det dagsaktuella läget, och han och övriga i ledningen kommer vara tillgängliga för att svara på frågor. Kalmar Datum: Onsdag 13 juni 2018 Tid: 18:00 - 20:00 CEST Plats: Kalmar Slott, Kungsgatan 1, 392 33 Kalmar För att delta på träffen, skicka ett mejl till email@example.com med ditt fullständiga namn. För ytterligare information kontakta: Carlos de Sousa, VD, Immunicum Telefon: +46 (0) 31 41 50 52 E-post: firstname.lastname@example.org Michaela Gertz, Finanschef, Immunicum Telefon: +46 (0) 31 41 50 52 E-post: email@example.com Media Relations Gretchen Schweitzer och Joanne Tudorica Trophic Communications Telefon: +49 172 861 8540 E-post: firstname.lastname@example.org Om Immunicum AB (publ) Immunicum etablerar ett unikt angreppssätt inom im
Immunicum AB: Invitation to Investor Event24.5.2018 08:00 | Pressmeddelande
Press Release 24 May 2018 Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18:00 CEST. Carlos de Sousa, CEO of Immunicum, will give the current corporate presentation and he and other members of the Immunicum leadership team will be available for a question and answer session. Kalmar Date: Wednesday, June 13, 2018 Time: 18:00 - 20:00 CEST Location: Kalmar Slott, Kungsgatan 1, 392 33 Kalmar To register to attend the event, please send an email to email@example.com with your full name. For more information, please contact: Carlos de Sousa, CEO, Immunicum Telephone: +46 (0) 31 41 50 52 E-mail: firstname.lastname@example.org Michaela Gertz, CFO, Immunicum Telephone: +46 70 926 17 75 E-mail: email@example.com Media Relations Gretchen Schweitzer and Joanne Tudorica Trophic Communications Telephone: +49 172 861 8540 E-mail: firstname.lastname@example.org About Immunicum AB (publ) Immunicum is establis
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum